UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Randomized Phase II Study Comparing the MET inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma
    Mohammed Milhem
  2. Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc P(1)
    Brian Link
  3. GOG 3001/ Amgen TRINOVA-3 - A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III…
    David Bender
  4. Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
    Ayman El-Sheikh
  5. A Phase III Randomized Trial of Gemcitabine (NSC# 613327) plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) vs. Observation for Uterus-limited, High Grade Uterine Leiomyosarcoma
    David Bender
  6. A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Lenalidomide, with and without Rituximab in Subjects with Rel…
    Brian Link
  7. A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination with Bendamustine and Rituximab (BR) in Subjects…
    Brian Link
  8. A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects With Previously Untreated, Unresecta…
    Mohammed Milhem
  9. Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination with Erlotinib in Pa(1)
    Daniel Vaena
  10. Randomized, double-blind phase III study of Pazopanib vs Placebo in subjects with metastatic renal cell carcinoma who have no evidence of disease following metastatectomy
    Daniel Vaena
  11. A Phase 2 Study of MLN8237 in Advanced / Metastatic Sarcoma(1)
    Mohammed Milhem
  12. Biobehavioral-Cytokine Interactions in Ovarian Cancer
    Susan Lutgendorf
  13. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of Tabalumab in Combination with Bortezomib and Dexamethasone in Patients with Previously Treated Multiple Myeloma
    Guido Tricot
  14. Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc Positive Diffuse Large B-Cell Lymphoma and Plasmablastic Lymphoma
    Brian Link
  15. A Phase III Randomized Trial of Adding Vincristine-topotecan-cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma
    Ayman El-Sheikh
  16. A randomized phase II study of Azacitidine in combination with Lenalidomide (NSC-703812) vs Azacitid(1)
    Thomas Carter
  17. Phase 2 study of the mTOR inhibitor everolimus in combination with bevacizumab in patients with sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors.…
    Mohammed Milhem
  18. Evaluation of Genes and Proteins in Pediatric Nervous System Tumors
    M. Sue O'Dorisio
  19. A Group-Wide Protocol for Collecting and Banking Research Specimens
    Ayman El-Sheikh
  20. Molecular Genetic Features of Acute Leukemia (CALGB 9862)
    Daniel Vaena

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.